Skip to main content
Steven A. Baker

Steven A. Baker, MD, PhD

Languages spoken: English
  • Dr. Steven Baker is a clinical pathologist specializing in transfusion medicine and hemostasis. Dr. Baker obtained a B.S. in Biological Sciences from Cornell University in 2005. He completed his MD and PhD training in the combined MSTP at Baylor College of Medicine in 2014. He then performed a residency in clinical pathology at Stanford University, before an instructorship in coagulation and fellowship training in transfusion medicine, also at Stanford. He joined the faculty of the University of Utah Department of Pathology as an Assistant Professor in 2021. He currently serves as the Associate Medical Director of Transfusion Medicine and Director of the Transfusion Residency Training Program.

    Specialties

    • Pathology, Clinical

    Board Certification

    American Board of Pathology (Clinical Path)
    American Board of Pathology (Sub: Blood Banking/Transfusion Medicine)
  • Dr. Steven Baker is a clinical pathologist specializing in transfusion medicine and hemostasis. Dr. Baker obtained a B.S. in Biological Sciences from Cornell University in 2005. He completed his MD and PhD training in the combined MSTP at Baylor College of Medicine in 2014. He then performed a residency in clinical pathology at Stanford University, before an instructorship in coagulation and fellowship training in transfusion medicine, also at Stanford. He joined the faculty of the University of Utah Department of Pathology as an Assistant Professor in 2021. He currently serves as the Associate Medical Director of Transfusion Medicine and Director of the Transfusion Residency Training Program.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Clinical Path)
    American Board of Pathology (Sub: Blood Banking/Transfusion Medicine)

    Education history

    Fellowship Transfusion Medicine - Stanford University School of Medicine Fellow
    Clinical Pathology - Stanford University School of Medicine Resident
    Doctoral Training Developmental Biology Program - Baylor College of Medicine Ph.D.
    Medicine - Baylor College of Medicine M.D.
    Undergraduate Biological Sciences - Cornell University B.S.

    Selected Publications

    Journal Article

    1. Montgomery H, Luo MX, Baker S, Lim MY (2023). An Unusual Case of Hyperhemolysis Syndrome and Delayed Hemolytic Transfusion Reaction due to Anti-Jk(a) and Anti-P1 Antibodies. Case Rep Med, 2023, 5290115. (Read full article)
    2. Potter S, Sudarshan D, Lzr-Molnr E, Baker S, Metcalf RA, Lin L (2022). Life threatening platelet transfusion refractoriness due to an anamnestic human leukocyte antigen alloantibody response. Transfusion, 62(11), 2161-2162. (Read full article)
    3. Baker SA, Wong LK, Wieland R, Bulterys P, Allard L, Nguyen L, Quach T, Nguyen A, Chaesuh E, Cheng P, Bowen R, Virk M (2022). Validated transport conditions maintain the quality of washed red blood cells. Transfusion, 62(9), 1860-1870. (Read full article)
    4. Baker SA, Gajera CR, Wawro AM, Corces MR, Montine TJ (2021). GATM and GAMT synthesize creatine locally throughout the mammalian body and within oligodendrocytes of the brain. Brain Res, 1770, 147627. (Read full article)
    5. Wawro AM, Gajera CR, Baker SA, Leniak RK, Montine KS, Fischer CR, Saw NL, Shamloo M, Montine TJ (2021). Enantiomers of 4-aminopentanoic acid act as false GABAergic neurotransmitters and impact mouse behavior. J Neurochem, 158(5), 1074-1082. (Read full article)
    6. Wawro AM, Gajera CR, Baker SA, Nirschl JJ, Vogel H, Montine TJ (2021). Creatine transport and pathological changes in creatine transporter deficient mice. J Inherit Metab Dis, 44(4), 939-948. (Read full article)
    7. Wawro AM, Gajera CR, Baker SA, Leniak RK, Fischer CR, Saw NL, Shamloo M, Montine TJ (2021). Enantiomers of 2-methylglutamate and 2-methylglutamine selectively impact mouse brain metabolism and behavior. Sci Rep, 11(1), 8138. (Read full article)
    8. Baker SA, Kwok S, Berry GJ, Montine TJ (2021). Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation. PLoS One, 16(2), e0247060. (Read full article)
    9. Baker SA, Jin J, Pfaffroth C, Vu T, Zehnder JL (2021). DOAC-Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples. Res Pract Thromb Haemost, 5(2), 314-325. (Read full article)

    Review

    1. Baker SA, Rutter J (2023). Metabolites as signalling molecules. [Review]. Nat Rev Mol Cell Biol, 24(5), 355-374. (Read full article)
  • News & Podcasts